Meridian Venture Partners II GP, L.P. ("GP") 13D and 13G filings for ANI Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-13 8:50 pm Sale |
2025-03-11 | 13D | ANI Pharmaceuticals, Inc. ANIP |
Meridian Venture Partners II GP, L.P. ("GP") | 1,184,570 5.400% |
-260,000 (-18.00%) |
Filing |
| 2024-03-14 07:30 am Sale |
2024-03-12 | 13D | ANI Pharmaceuticals, Inc. ANIP |
Meridian Venture Partners II GP, L.P. ("GP") | 1,444,570 6.900% |
-232,855 (-13.88%) |
Filing |
| 2023-12-18 5:18 pm Sale |
2023-12-14 | 13D | ANI Pharmaceuticals, Inc. ANIP |
Meridian Venture Partners II GP, L.P. ("GP") | 1,677,425 8.200% |
-190,855 (-10.22%) |
Filing |
| 2023-08-17 6:22 pm Sale |
2023-08-16 | 13D | ANI Pharmaceuticals, Inc. ANIP |
Meridian Venture Partners II GP, L.P. ("GP") | 1,868,280 9.200% |
-200,000 (-9.67%) |
Filing |
| 2022-12-12 4:00 pm Purchase |
2022-12-01 | 13D | ANI Pharmaceuticals, Inc. ANIP |
Meridian Venture Partners II GP, L.P. ("GP") | 2,068,280 11.800% |
2,068,280 (New Position) |
Filing |